CD274 and neoplasm: Previous studies in preclinical models of cancer have indicated that chemotherapeutic agents such as CPX can often have direct effects on tumor cells that are relevant to immune responses, including up-regulating the expression of immune checkpoint molecules such as PD-L1 and of MHC class I molecules [6,20,21,22,23].